Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors Biotech Investing
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares Biotech Investing
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update Biotech Investing
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain Biotech Investing
Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer Biotech Investing
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting Biotech Investing
